82
62
Growth Score 82 in past quarter
-1 pts
Heat Score 62 in past quarter
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
566799
Celentyx is a CRO offering bespoke assay services in human immunology, including immuno-oncology, autoimmunity & inflammation, fibrosis.
- John Gordon: Co-Founder, Chief Scientific Officer, Director & Board Member
- Nicholas Barnes: Co-Founder, Chief Executive Officer, Director & Board Member
About the Company
Celentyx Ltd is a CRO offering bespoke assay services in human immunology, including immuno-oncology, autoimmunity & inflammation, fibrosis and neuroinflammation. Drawing on the World-leading expertise of Celentyx personnel, along with our close association with the MRC Centre for Immune Regulation and the Centre for Translational Inflammation
Research enables the human immune system in health and disease to be investigated at the highest levels of resolution.